C-terminally truncated interferon

Details for Australian Patent Application No. 2005269364 (hide)

Owner Large Scale Biology Corporation

Inventors Pogue, Gregory P.; Reinl, Stephen J.

Agent Davies Collison Cave

Pub. Number AU-A-2005269364

PCT Pub. Number WO2006/015057

Priority 11/172,549 29.06.05 US; 60/592,479 29.07.04 US

Filing date 27 July 2005

Wipo publication date 9 February 2006

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

C07K 14/56 (2006.01) Peptides having more than 20 amino acids

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/015057 Priority application(s): WO2006/015057

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005269367-Isoindoline compounds and methods of their use

2005269362-Method of treating hyperphosphataemia using lanthanum hydroxycarbonate